Stock 301130 JILIN PROVINCE XIDIAN PHARMACEUTICAL SCI-TECH DEVELOPMENT CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd

Equities

301130

CNE1000058C4

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 15/07/2024 am IST 		5-day change 1st Jan Change
23.11 CNY -3.31% Intraday chart for Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd -0.22% -17.11%
01/07 Tranche Update on Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd's Equity Buyback Plan announced on February 29, 2024. CI
04/06 Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 12 June 2024 CI

Valuation

Fiscal Period: December 2022 2023
Capitalization 1 2,333 2,253
Enterprise Value (EV) 1 1,717 1,703
P/E ratio 54.9 x 44.6 x
Yield 0.55% 0.93%
Capitalization / Revenue 9.13 x 9.99 x
EV / Revenue 6.72 x 7.55 x
EV / EBITDA 31.3 x 37.6 x
EV / FCF 702 x -24.9 x
FCF Yield 0.14% -4.02%
Price to Book 2.47 x 2.29 x
Nbr of stocks (in thousands) 80,804 80,804
Reference price 2 28.87 27.88
Announcement Date 20/04/23 22/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 280.2 324.9 286.3 285.7 255.5 225.5
EBITDA 1 59.65 77.76 68.89 66.96 54.77 45.32
EBIT 1 41.71 57.08 48.43 48.25 36.28 26.77
Operating Margin 14.89% 17.57% 16.92% 16.89% 14.2% 11.87%
Earnings before Tax (EBT) 1 48.34 64.41 58.93 59.21 50.43 58.31
Net income 1 41.36 54.61 49.74 52.02 40.72 50.5
Net margin 14.76% 16.81% 17.37% 18.21% 15.94% 22.4%
EPS 2 0.6825 0.9012 0.8208 0.8584 0.5259 0.6250
Free Cash Flow 1 7.536 32.2 26.48 15.27 2.444 -68.43
FCF margin 2.69% 9.91% 9.25% 5.35% 0.96% -30.35%
FCF Conversion (EBITDA) 12.63% 41.42% 38.44% 22.81% 4.46% -
FCF Conversion (Net income) 18.22% 58.97% 53.23% 29.36% 6% -
Dividend per Share - - - 0.1300 0.1600 0.2600
Announcement Date 17/07/20 17/07/20 27/01/22 24/04/22 20/04/23 22/04/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 116 152 176 215 616 550
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 7.54 32.2 26.5 15.3 2.44 -68.4
ROE (net income / shareholders' equity) 10.5% 12.7% 10.8% 10.4% 5.54% 5.24%
ROA (Net income/ Total Assets) 5.36% 6.91% 5.6% 5.27% 2.81% 1.61%
Assets 1 771.4 790.2 888.6 987.8 1,447 3,146
Book Value Per Share 2 6.770 7.370 7.790 8.650 11.70 12.20
Cash Flow per Share 2 1.910 1.670 1.780 2.450 2.510 4.140
Capex 1 31.1 13.2 14.5 21.2 54.4 123
Capex / Sales 11.09% 4.08% 5.07% 7.42% 21.29% 54.62%
Announcement Date 17/07/20 17/07/20 27/01/22 24/04/22 20/04/23 22/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
JILIN PROVINCE XIDIAN PHARMACEUTICAL SCI-TECH DEVELOPMENT CO.,LTD Stock Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
-17.11% 249M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+63.32% 856B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+38.95% 631B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.28% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.45% 325B
ABBVIE INC. Stock AbbVie Inc.
+8.53% 297B
ROCHE HOLDING AG Stock Roche Holding AG
+5.89% 234B
NOVARTIS AG Stock Novartis AG
+16.50% 226B
AMGEN INC. Stock Amgen Inc.
+15.15% 177B
PFIZER, INC. Stock Pfizer, Inc.
+1.84% 165B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 301130 Stock
  4. Financials Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd